Nicolaus Kröger
Nicolaus Kröger
Professor der Medizin
Verified email at uke.de
Title
Cited by
Cited by
Year
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study
SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ...
Leukemia 26 (1), 149-157, 2012
8572012
Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet
T Barbui, G Barosi, G Birgegard, F Cervantes, G Finazzi, M Griesshammer, ...
Journal of Clinical Oncology 29 (6), 761, 2011
8482011
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and …
RA Kyle, BGM Durie, SV Rajkumar, O Landgren, J Bladé, G Merlini, ...
Leukemia 24 (6), 1121-1127, 2010
7592010
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
R Zeiser, A Burchert, C Lengerke, M Verbeek, K Maas-Bauer, ...
Leukemia 29 (10), 2062-2068, 2015
4052015
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
JR Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, ...
Bone marrow transplantation 51 (6), 786-792, 2016
4042016
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party …
N Kröger, E Holler, G Kobbe, M Bornhäuser, R Schwerdtfeger, ...
Blood, The Journal of the American Society of Hematology 114 (26), 5264-5270, 2009
3992009
Antilymphocyte globulin for prevention of chronic graft-versus-host disease
N Kröger, C Solano, C Wolschke, G Bandini, F Patriarca, M Pini, A Nagler, ...
New England Journal of Medicine 374 (1), 43-53, 2016
3812016
International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation
M Cavo, SV Rajkumar, A Palumbo, P Moreau, R Orlowski, J Bladé, ...
Blood, The Journal of the American Society of Hematology 117 (23), 6063-6073, 2011
3482011
Indications for allo-and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015
A Sureda, P Bader, S Cesaro, P Dreger, RF Duarte, C Dufour, ...
Bone marrow transplantation 50 (8), 1037-1056, 2015
3322015
Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma
N Kröger, R Schwerdtfeger, M Kiehl, HG Sayer, H Renges, T Zabelina, ...
Blood, The Journal of the American Society of Hematology 100 (3), 755-760, 2002
2982002
Outcome of transplantation for myelofibrosis
KK Ballen, S Shrestha, KA Sobocinski, MJ Zhang, A Bashey, BJ Bolwell, ...
Biology of Blood and Marrow Transplantation 16 (3), 358-367, 2010
2862010
Revised response criteria for myelofibrosis: international Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus …
A Tefferi, F Cervantes, R Mesa, F Passamonti, S Verstovsek, ...
Blood, The Journal of the American Society of Hematology 122 (8), 1395-1398, 2013
2752013
Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report
JR Passweg, H Baldomero, P Bader, C Bonini, RF Duarte, C Dufour, ...
Bone marrow transplantation 52 (6), 811-817, 2017
2742017
Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice
T Ruutu, A Gratwohl, T De Witte, B Afanasyev, J Apperley, A Bacigalupo, ...
Bone marrow transplantation 49 (2), 168-173, 2014
2712014
Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet
T Barbui, A Tefferi, AM Vannucchi, F Passamonti, RT Silver, R Hoffman, ...
Leukemia 32 (5), 1057-1069, 2018
2672018
International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment
MA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, ...
Journal of Clinical Oncology 34 (13), 1544-1557, 2016
2662016
Phase II clinical trial of titanocene dichloride in patients with metastatic breast cancer
N Kröger, UR Kleeberg, K Mross, L Edler, DK Hossfeld
Oncology Research and Treatment 23 (1), 60-62, 2000
2392000
Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant …
MG Kiehl, L Kraut, R Schwerdtfeger, B Hertenstein, M Remberger, ...
Journal of Clinical Oncology 22 (14), 2816-2825, 2004
2272004
Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete …
M Bornhäuser, J Kienast, R Trenschel, A Burchert, U Hegenbart, ...
The lancet oncology 13 (10), 1035-1044, 2012
2232012
Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group
NM Kröger, JH Deeg, E Olavarria, D Niederwieser, A Bacigalupo, ...
Leukemia 29 (11), 2126-2133, 2015
2202015
The system can't perform the operation now. Try again later.
Articles 1–20